Analysts Set Omega Healthcare Investors, Inc. (NYSE:OHI) Target Price at $39.70

Shares of Omega Healthcare Investors, Inc. (NYSE:OHI) have earned an average recommendation of “Hold” from the twelve ratings firms that are presently covering the stock, MarketBeat reports. Seven equities research analysts have rated the stock with a hold recommendation and five have issued a buy recommendation on the company. The average twelve-month target price among analysts that have issued a report on the stock in the last year is $40.00.

A number of brokerages have recently issued reports on OHI. Royal Bank of Canada lifted their target price on Omega Healthcare Investors from $39.00 to $43.00 and gave the stock a “sector perform” rating in a research report on Monday. Mizuho lowered Omega Healthcare Investors from an “outperform” rating to a “neutral” rating and upped their target price for the company from $34.00 to $35.00 in a research report on Thursday, July 25th. BNP Paribas upgraded Omega Healthcare Investors from a “neutral” rating to an “outperform” rating and set a $49.00 target price for the company in a research note on Thursday, October 31st. Wells Fargo & Company restated an “overweight” rating and issued a $43.00 price target (up previously from $40.00) on shares of Omega Healthcare Investors in a research note on Tuesday, October 1st. Finally, Scotiabank increased their price objective on shares of Omega Healthcare Investors from $33.00 to $39.00 and gave the company a “sector perform” rating in a research note on Monday, August 26th.

Insider Activity at Omega Healthcare Investors

In other Omega Healthcare Investors news, CFO Robert O. Stephenson sold 22,542 shares of the firm’s stock in a transaction dated Friday, September 27th. The shares were sold at an average price of $40.19, for a total value of $905,962.98. Following the transaction, the chief financial officer now owns 183,076 shares of the company’s stock, valued at $7,357,824.44. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. In related news, CFO Robert O. Stephenson sold 22,542 shares of the company’s stock in a transaction on Friday, September 27th. The stock was sold at an average price of $40.19, for a total transaction of $905,962.98. Following the completion of the transaction, the chief financial officer now directly owns 183,076 shares in the company, valued at $7,357,824.44. This represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, COO Daniel J. Booth sold 56,725 shares of the firm’s stock in a transaction on Friday, September 27th. The shares were sold at an average price of $40.25, for a total value of $2,283,181.25. Following the completion of the sale, the chief operating officer now owns 100,000 shares in the company, valued at $4,025,000. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 1.37% of the company’s stock.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of the company. Versant Capital Management Inc bought a new stake in shares of Omega Healthcare Investors during the second quarter valued at approximately $26,000. UMB Bank n.a. raised its stake in Omega Healthcare Investors by 353.4% during the 3rd quarter. UMB Bank n.a. now owns 662 shares of the real estate investment trust’s stock valued at $27,000 after acquiring an additional 516 shares in the last quarter. DiNuzzo Private Wealth Inc. acquired a new position in Omega Healthcare Investors during the 3rd quarter worth $33,000. V Square Quantitative Management LLC grew its stake in shares of Omega Healthcare Investors by 49.5% in the third quarter. V Square Quantitative Management LLC now owns 976 shares of the real estate investment trust’s stock worth $40,000 after purchasing an additional 323 shares in the last quarter. Finally, Covestor Ltd increased its holdings in shares of Omega Healthcare Investors by 47.6% during the first quarter. Covestor Ltd now owns 1,337 shares of the real estate investment trust’s stock valued at $42,000 after purchasing an additional 431 shares during the period. 65.25% of the stock is owned by institutional investors and hedge funds.

Omega Healthcare Investors Stock Performance

Omega Healthcare Investors stock opened at $41.39 on Friday. Omega Healthcare Investors has a 12-month low of $27.53 and a 12-month high of $44.42. The company has a debt-to-equity ratio of 1.10, a current ratio of 6.48 and a quick ratio of 6.48. The company has a market capitalization of $11.17 billion, a price-to-earnings ratio of 30.43, a price-to-earnings-growth ratio of 1.33 and a beta of 0.99. The firm’s fifty day moving average price is $40.59 and its 200 day moving average price is $36.40.

Omega Healthcare Investors Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, November 15th. Stockholders of record on Monday, November 4th will be given a $0.67 dividend. The ex-dividend date of this dividend is Monday, November 4th. This represents a $2.68 dividend on an annualized basis and a dividend yield of 6.47%. Omega Healthcare Investors’s payout ratio is currently 197.06%.

Omega Healthcare Investors Company Profile

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.